Test Price
750 AED✅ Home Collection Available
HCV Viral Load Quantitative Test in Dubai | 750 AED | DHA Licensed PCR
Executive Summary & Core Metrics
- ● Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Real-Time PCR Processing at DHA Licensed Facility 1143.
- ● Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Daily 8 AM – 11 PM).
- ● Clinical Guidance: Telephonic Post-Test Clinical Guidance for Result Interpretation by a Registered General Practitioner.
- ● Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The HCV Viral Load Quantitative Test precisely measures the concentration of Hepatitis C virus RNA in peripheral blood using real-time polymerase chain reaction (qPCR) technology. This assay distinguishes active infection from past exposure, guides antiviral therapy initiation, and monitors treatment response over time. Results are reported in IU/mL with a lower detection threshold of 15 IU/mL, enabling early identification of virologic breakthrough or sustained virologic response.
| Feature | HCV Viral Load (qPCR) | HCV Antibody Test (ELISA) |
|---|---|---|
| Detection Target | Quantitative viral RNA — confirms active infection | IgG antibodies — past exposure only |
| Method | Real-Time PCR (99.9% sensitivity, 99.8% specificity) | ELISA (variable sensitivity ~95%) |
| Turnaround Time | 24 hours (telephonic) / 36 hours (email report) | 2 – 3 business days |
| Clinical Utility | Confirm active infection, guide DAA therapy, monitor SVR | Initial screening; does not differentiate active vs. resolved |
Physician Insight & Safety Protocols
“From a clinical perspective, the HCV viral load must always be interpreted alongside liver enzyme panels (ALT, AST) and FibroScan or biopsy findings to stage disease accurately. Never initiate, adjust, or stop direct-acting antiviral medications without consulting your physician — our telephonic guidance service bridges that gap with evidence-based advice tailored to your result profile. Consistent monitoring every 4–12 weeks during therapy ensures optimal outcomes and minimizes relapse risk.”
— Dr. Ajay Singh, General Practitioner | DHA Registration ID: 36234132
Medication Advisory – Do Not Self-Alter Therapy
Hepatitis C antiviral regimens (e.g., sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) require strict adherence for 8–12 weeks. Abrupt discontinuation can lead to virologic relapse, drug resistance, or hepatic flare. Always consult your prescribing hepatologist before making any changes to your medication schedule.
Patient Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Patients with acute hepatic decompensation (encephalopathy, ascites, variceal hemorrhage), haemodynamic instability, active severe coagulopathy (INR >2.5), or inability to provide informed consent.
- Emergency Red Flags: If you experience sudden jaundice, confusion, severe right upper quadrant pain, hematemesis, or melena after sample collection, proceed to the nearest emergency department immediately.
For minors under 18 years, written informed consent from a legal guardian is mandatory per Federal Decree-Law No. 4 of 2016 on Medical Liability.
Patient FAQ & Clinical Guidance
1. What does my HCV viral load result mean?
An HCV RNA result below 15 IU/mL is considered undetectable, indicating no active viral replication. A result of 15 IU/mL or higher confirms active Hepatitis C infection. Serial quantitative measurements taken every 4–12 weeks during treatment track viral decline; a sustained undetectable result 12 or 24 weeks after completing therapy defines cure (SVR12/SVR24).
2. How is the blood sample collected for this test?
A standard venipuncture draws 5–10 mL of whole blood into a serum separator tube. Our DHA-licensed phlebotomist performs the procedure at your home or office under aseptic technique. The sample is immediately placed in a temperature-controlled cold-chain transport box (2–8°C) and delivered to our ISO 9001:2015 accredited laboratory within 2 hours for plasma separation and RNA extraction.
3. Who should undergo HCV viral load testing?
Testing is recommended for individuals with any of the following: prior blood transfusion before 1992, history of intravenous drug use, elevated liver enzymes (ALT >40 U/L), hemodialysis patients, healthcare workers after needlestick injury, children born to HCV-positive mothers, and anyone with unexplained chronic liver disease. UAE screening guidelines also recommend one-time testing for adults born between 1945 and 1965.
4. Do I need to fast before the blood draw?
Fasting is not required for HCV RNA testing alone. However, if your physician has ordered simultaneous liver enzyme or lipid panels, a 10–12 hour fast from food (water permitted) is preferable. Confirm with our team when booking your appointment.
UAE Regulatory & Data Privacy Adherence
- ✓ Data Protection: All personal health information is processed in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- ✓ Medical Liability: Patient safety protocols and informed consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
- ✓ DHA Licensing: DNA Labs UAE operates under DHA Facility License Number 1143, with all testing personnel holding current DHA professional registration.
- ✓ Data Security: Results are transmitted via encrypted channels; physical records are stored in access-controlled archives with 5-year retention per UAE health authority requirements.
Clinical & Logistical Metadata
| Test Name | HCV Viral Load Quantitative Test (Real-Time PCR) |
| Price (AED) | 750 AED |
| Turnaround Time | 24 hours (telephonic result) / 36 hours (detailed email report) |
| Sample Type / Matrix | Peripheral whole blood (5–10 mL venipuncture, serum separator tube) |
| Methodology Used | Real-Time Quantitative Reverse Transcription PCR (qRT-PCR), lower limit of detection 15 IU/mL |
| ICD-10-CM Code | B19.20 (Unspecified viral hepatitis C without hepatic coma), B17.11 (Acute hepatitis C with hepatic coma), B18.2 (Chronic viral hepatitis C) |
| LOINC Code | 11011-4 (Hepatitis C virus RNA [log IU/mL] in Serum or Plasma by NAA with probe detection) |
| DHA Facility License & Laboratory Address | DHA License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians